Clínica Universidad de Navarra
Pamplona, Navarre, 31008, Spain
NCT Number: NCT07565649
This study aims to evaluate the clinical impact of the systematic implementation of point-of-care ultrasound (POCUS) in the management of patients with septic shock in the intensive care unit (ICU).
Septic shock is associated with high morbidity and mortality, and its management requires timely and accurate hemodynamic assessment. Traditional monitoring methods have limitations in evaluating cardiac function, fluid responsiveness, and tissue perfusion. POCUS provides real-time, bedside, non-invasive assessment that may improve clinical decision-making.
This is a retrospective, single-center cohort study comparing two time periods: a pre-implementation cohort (2016-2019) and a post-implementation cohort (2022-2025), excluding the COVID-19 pandemic period. The primary objective is to assess whether the implementation of POCUS is associated with an improvement in early organ dysfunction, measured as the change in SOFA score at 48 hours (delta SOFA). Secondary outcomes include mortality at 28, 60, and 90 days, incidence of acute kidney injury, duration of organ support therapies, and length of ICU and hospital stay.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Pamplona, Navarre, 31008, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline (ICU admission) and 48 hours after ICU admission
Difference between the Sequential Organ Failure Assessment (SOFA) score at ICU admission and at 48 hours.
Time frame: Up to 28 days after ICU admission
All-cause mortality within 28 days from ICU admission
Time frame: Up to 60 days after ICU admission
All-cause mortality within 60 days from ICU admission
Time frame: Up to 90 days after ICU admission
All-cause mortality within 90 days from ICU admission
Time frame: From ICU admission to ICU discharge
Occurrence of acute kidney injury during ICU stay
Time frame: From ICU admission to day 28
Number of days alive and free from vasopressor support within the first 28 days after ICU admission
Time frame: From ICU admission to day 28
Number of days alive and free from mechanical ventilation within the first 28 days after ICU admission
Time frame: From ICU admission to day 28
Number of days alive and free from renal replacement therapy within the first 28 days after ICU admission
Time frame: From ICU admission to day 28
Length of stay in the intensive care unit
Time frame: Through hospital discharge, an average of 28 days
Total length of hospital stay
Time frame: Baseline (ICU admission), 24 hours, and 72 hours
Change in quick Sequential Organ Failure Assessment (qSOFA) score at 24 and 72 hours from ICU admission
Clinica Universidad de Navarra, Universidad de Navarra
Other
Impact of Systematic Implementation of Point-of-Care Ultrasound on Clinical Course and Survival in Patients With Septic Shock: A Retrospective Single-Center Cohort Study
Acronym: SHOCK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07658014
Cardiovascular Diseases, Infections
Querétaro City, Querétaro, Mexico
View Trial DetailsNCT05900284
Acute Kidney Injury, Female Urogenital Diseases
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT05194189
Infections, Inflammation
Guanzhou, Guangdong, China
View Trial DetailsNCT07401329
Infections, Inflammation
Rohtak, Haryana, India
View Trial Details